SCHEMBL502845

SCHEMBL502845

Fc1ccc(F)c(F)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29628989 1.00
SCHEMBL15624392 0.75
SCHEMBL1191752 0.71 APP (0.35)
SCHEMBL845963 0.71
SCHEMBL22824181 0.71
SCHEMBL908784 0.71
SCHEMBL19437238 0.71
SCHEMBL2222123 0.71
SCHEMBL9157488 0.71
SCHEMBL432833 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240242971-A1 NITROGEN-CONTAINING AROMATIC OR RING STRUCTURE MOLECULES FOR PLASMA ETCH AND DEPOSITION AMERICAN AIR LIQUIDE, INC. 2024-07-18 US claimed
WO-2024145170-A1 NITROGEN-CONTAINING AROMATIC OR RING STRUCTURE MOLECULES FOR PLASMA ETCH AND DEPOSITION L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2024-07-04 WO claimed
CN-115602926-B High-temperature-resistant electrolyte and preparation method and application thereof 河北省科学院能源研究所 2023-04-28 CN claimed
CN-115602926-A High-temperature-resistant electrolyte and preparation method and application thereof 河北省科学院能源研究所(CN) 2023-01-13 CN claimed
CN-115084655-A Electrolyte, preparation method thereof and lithium metal battery containing electrolyte 蜂巢能源科技(无锡)有限公司 2022-09-20 CN claimed
US-12642026-B2 Nitrogen-containing aromatic or ring structure molecules for plasma etch and deposition AMERICAN AIR LIQUIDE, INC. (US) 2026-05-26 US disclosed
US-12479818-B2 Treatment of fibrosis with IRE1 small molecule inhibitors CORNELL UNIVERSITY (US) 2025-11-25 US disclosed
US-12433895-B2 Therapeutically active compounds and their methods of use SERVIER PHARMACEUTICALS LLC (US) 2025-10-07 US disclosed
US-20250270196-A1 GLP-1 Receptor Agonists and Uses Thereof PFIZER INC. (US) 2025-08-28 US disclosed
US-20250205232-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-06-26 US disclosed
US-12331041-B2 GLP-1 receptor agonists and uses thereof PFIZER INC. (US) 2025-06-17 US disclosed
EP-3707126-B1 IRE1 SMALL MOLECULE INHIBITORS UNIV CORNELL (US) 2025-05-14 EP disclosed
EP-0556737-B1 Process for the preparation of substituted 2,3-difluoro-pyridines CLARIANT GMBH (DE) 2000-01-12 EP disclosed
EP-0519370-B1 Heterocyclic derivatives MERCK PATENT GMBH (DE) 1997-11-05 EP disclosed
US-5468863-A Process for the preparation of substituted 2,3-difluoropyridines HOECHST AKTIENGESELLSCHAFT (DE) 1995-11-21 US disclosed
EP-0556737-A1 Process for the preparation of substituted 2,3-difluoro-pyridines HOECHST AKTIENGESELLSCHAFT (DE) 1993-08-25 EP disclosed
EP-0519370-A2 Heterocyclic derivatives MERCK PATENT GmbH (DE) 1992-12-23 EP disclosed
EP-0146924-B1 PREPARATION OF DIFLUORPYRIDINE COMPOUNDS THE DOW CHEMICAL COMPANY (US) 1989-06-07 EP disclosed
EP-0146924-A2 Preparation of difluorpyridine compounds THE DOW CHEMICAL COMPANY (US) 1985-07-03 EP disclosed
US-3947457-A Method for preparing 2,5-dihalo- and 2,5,6-trihalopyridines THE DOW CHEMICAL COMPANY (US) 1976-03-30 US disclosed